New research may lead to new targeted treatments for rheumatoid arthritis (RA), an autoimmune disease that causes joint inflammation and destruction. New research led by University of Colorado School ...
Whether you are seeking information for yourself or a loved one, read on to learn more about the disease and how to better understand its signs and symptoms. Rheumatoid arthritis is an inflammatory ...
Dry needling is similar to acupuncture and may offer some relief from rheumatoid arthritis. However, there’s limited evidence to support the benefits of this therapy. Dry needling is a therapy that ...
Treatments and outcomes for rheumatoid arthritis (RA) have made major advances in the last decade. Earlier diagnoses, better treatment strategies, and improvements in disease modifying anti-rheumatic ...
Rheumatoid arthritis is a painful and disabling autoimmune disease that affects more than 1% of people worldwide. In the United States alone, it disrupts the lives of about 1.3 million people. The ...
Everyday Health on MSN
Aging with rheumatoid arthritis: Challenges and adaptations
Learn how aging with rheumatoid arthritis presents challenges and comorbidities, and why aggressive treatment remains crucial in older adults.
—Investigators conducted a secondary analysis of the TARGET trial to determine differences in cardiovascular risk between rheumatoid arthritis patients treated with triple therapy or tumor necrosis ...
Q. I have had rheumatoid arthritis for a while, and wonder if there are any new treatments available. A. There are many different types of arthritis. Many of us-- especially as we age -- develop joint ...
Rheumatoid arthritis (RA) is a painful joint condition that affects about 1.5 million people in the United States. Pain, tenderness, and stiffness are often the first symptoms of RA and can affect ...
Interleukin-6 (IL-6) is a pleiotropic cytokine that may play a role in the regulation of various aspects of the immune response, inflammation, hematopoiesis, and bone metabolism. IL-6 acts by binding ...
MedPage Today on MSN
Rheumatoid arthritis: How best to gauge ILD risk in light of comorbidities?
Standard tools don't help, study finds, but a specialized assessment does ...
The rheumatoid arthritis market is poised for growth due to the rising adoption of advanced disease-modifying therapies, fostering deeper patient retention and consistent demand. Challenges include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results